FORWARD PHARMA A/S
SPONSORD ADS NEW · CUSIP 34986J204
2
institutional holders
-6 vs Q3 2022
211.7k
shares reported held*
$411.9kreported value*
0 new
0 added
0 reduced
6 sold out
net sold ≈ $1.4m (-697.4k shares)
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $1.95.
Trends to Q4 2022
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q3 2022 | 8 |
| Q4 2022 | 2 |
Biggest buyers
| None |
Biggest sellers
| BVF INC/IL | Sold out | -513.8k |
| MORGAN STANLEY | Sold out | -163.3k |
| Perigon Wealth Management, LLC | Sold out | -18.1k |
| UBS Group AG | Sold out | -2.2k |
| OSAIC HOLDINGS, INC. | Sold out | -1 |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | Sold out | 0 |
Holders, Q4 2022
| Manager | Shares | Change |
|---|---|---|
| MASON CAPITAL MANAGEMENT LLC 0.13% of their portfolio | 150.2k $292.9k | Unchanged |
| ACADIAN ASSET MANAGEMENT LLC 0.00% of their portfolio | 61.5k $119.0k | Unchanged |